LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (Nasdaq: CBRX) announced today that as of March 10, its Board of Directors elected Frank C. Condella, Jr. as a director of the Company. Mr. Condella is a non-executive director of Skyepharma plc and Fulcrum Pharma plc.
